| CAS NO: | 1291094-73-9 |
| 规格: | 98% |
| 分子量: | 416.46 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
Licogliflozin (LIK066) is a non-anti-fibrotic treatment agent for non-alcoholic steatohepatitis (NASH).
[1]. Monica A. Konerman, et al. Overview of Clinical Treatment Trials for NASH.Curr Hepatol Rep. 2017 Dec;16(4): 366-373.
